Keywords
COVID-19; SARS-CoV-2; BA.5; Omicron; Paxlovid; CDC: Centers for Disease Control and Prevention; FDA: U.S. Food and Drug Administration; WHO: World Health Organization
Abstract
NA
Most read articles by the same author(s)
- Sohail Rao, Manish Singh, Efraim Vela, COVID-19 Vaccination During Pregnancy and Breast Feeding is Safe and Effective , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Caitlin White, Manish Singh, Is There Any Advantage of Using Polyclonal vs. Monoclonal Antibodies for Passive Enhancement of Immunity in Patients with COVID-19? , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- Sohail Rao, Manish Singh, Engineering of Viruses and Pathogens for Gain-of-Function Research , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Messenger RNA Vaccines are Safe & Effective and do not Modify Host DNA , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, MD, FACS, Why Should Vaccinated People Wear Masks Indoors in Areas of High Community Transmission , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Manish Singh, What is the Definition of being Fully Vaccinated? , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- R. Armour Forse, Anthony O. Obinna, Manish Singh, Don't Don’t abandon your mask (and other public health measures) quite yet. , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- sohail Rao, Is the Public Outcry for Johnson & Johnson Jansen’s COVID-19 Vaccine Causing Blood Clots Justified? , DHR Proceedings: Vol. 1 No. S2 (2021): Special Publication: Editorial on COVID-19 Vaccine
- Sohail Rao, Manish Singh, Khushboo Hemnani, Carlos Arroyo, Can we Abandon our Masks? Deciphering CDC’s New Guidelines about Masking , DHR Proceedings: Vol. 2 No. S1 (2022): First Quarter 2022
- Sohail Rao, Challenges and Opportunities in Conducting Translational and Clinical Research in Academic Institutions and Universities , DHR Proceedings: Vol. 2 No. S1 (2022): First Quarter 2022